================================================================================


                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                    FORM 8-K

                CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF
                       THE SECURITIES EXCHANGE ACT OF 1934


       DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): AUGUST 10, 2004


                               AROTECH CORPORATION
             (Exact name of registrant as specified in its charter)


           DELAWARE                   0-23336                  95-4302784
 (State or other jurisdiction       (Commission               (IRS Employer
      of incorporation)             File Number)           Identification No.)


 250 WEST 57TH STREET, SUITE 310, NEW YORK, NEW YORK              10107
       (Address of Principal Executive Offices)                (Zip Code)


       REGISTRANT'S TELEPHONE NUMBER, INCLUDING AREA CODE: (212) 258-3222



          (Former name or former address, if changed since last report)


================================================================================




ITEM 7.  FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS

         (c) Exhibits. A list of exhibits required is given in the Exhibit Index
that precedes the exhibits filed with this report.

ITEM 12. RESULTS OF OPERATIONS AND FINANCIAL CONDITION.

         On August 10, 2004, we publicly  disseminated an earnings  release (the
"Release") announcing our financial results for the quarter ended June 30, 2004.
A copy of the Release is attached as Exhibit 99.1 hereto.

         The  information  included  in  the  attached  Exhibit  99.1  is  being
furnished  and shall not be deemed  "filed"  for  purposes  of Section 18 of the
Securities  Exchange  Act of 1934,  as  amended,  or  otherwise  subject  to the
liabilities of that Section,  or  incorporated  by reference in any filing under
the Securities Act of 1933, as amended,  or the Securities Exchange Act of 1934,
as amended, except as shall be expressly set forth by specific reference in such
a filing.

         To  supplement  the  consolidated  financial  results as  determined in
accordance with generally accepted accounting  principles ("GAAP"),  the Release
presents a non-GAAP financial measure,  "Adjusted LBITDA" (Loss Before Interest,
Taxes,  Depreciation and  Amortization,  adjusted to eliminate  certain non-cash
charges).   We  believe  that  the  use  of  Adjusted  LBITDA  enhances  overall
understanding  of  our  current  financial  performance.   As  required  by  the
Securities and Exchange Commission,  Adjusted LBITDA is reconciled to Net Profit
(Loss) in the Release.

                                   SIGNATURES

         Pursuant to the  requirements  of the Securities  Exchange Act of 1934,
the  Registrant  has duly  caused  this report to be signed on its behalf by the
undersigned hereunto duly authorized.

                                AROTECH CORPORATION
                                (REGISTRANT)


                                By: /s/ Robert S. Ehrlich
                                    -------------------------------------------
                                    Name:   Robert S. Ehrlich
                                    Title:  President, Chairman of the Board and
                                            Chief Executive Officer

Dated:  August 10, 2004


                                       2


                                  EXHIBIT INDEX


         The following exhibits are filed with the Current Report on Form 8-K.

            EXHIBIT
            NUMBER                   DESCRIPTION
            -------                  -----------

             99.1         Earnings press release dated August 10, 2004



                                       3



                 [AROTECH LOGO]
                                                                   EARNINGS NEWS
  250 West 57th Street, Suite 310, New York, NY 10107
       Tel: (212) 258-3222 o Fax: (212) 258-3281
                    www.arotech.com

FOR IMMEDIATE RELEASE
---------------------

                AROTECH CORPORATION REPORTS RECORD SECOND QUARTER
                             AND FIRST HALF REVENUES

                                   -----------

                  Backlog including AoA now at $37.0 million -
                   positive EBITDA anticipated for second half

        NEW YORK,  NEW YORK,  AUGUST 10, 2004 - AROTECH  CORPORATION  (NasdaqNM:
ARTX), a provider of quality defense and security products for the military, law
enforcement and security  markets,  today reported second quarter and first half
2004 results.

        The Company reported that revenues for the quarter were $9.9 million, an
increase  of 184%  over the  corresponding  period  in 2003.  The  Company  also
reported that backlog as of the end of June 2004 stood at $25.6  million,  which
increases to $37.0  million  with the  addition of Armour of America's  backlog.
Adjusted  LBITDA was reduced  substantially  compared to the same  quarter  last
year.  Net loss  increased  over the same  period  last year,  primarily  due to
non-cash charges associated with acquisitions and financings.

        Arotech  Chairman and CEO Robert S. Ehrlich  commented,  "Once again, we
are able to report record revenues. This quarter's revenues represent our eighth
consecutive  quarter of revenue growth," continued Ehrlich.  "For the first time
ever, our operating cash exceeded our cash expenses, and we anticipate achieving
positive  EBITDA  beginning  in the second half of 2004 and  beyond,"  concluded
Ehrlich.

CONFERENCE CALL

         Arotech Corporation will hold it second quarter 2004 conference call on
Wednesday,  August 11, 2004 at 11:00 a.m. EDT. Those wishing to take part in the
conference   call   should   call   1-888-695-0608   (US)   or   +1-719-457-2659
(international) a few minutes before the 11:00 a.m. EDT start time. In addition,
an instant replay will be available Wednesday,  August 11, 2004 at 1:00 p.m. EDT
until Friday,  August 13, 2004 at 8:00 p.m. EDT. The replay  telephone number is
1-888-203-1112 (US); +1-719-457-0820 (international). The confirmation number is
138511.

RESULTS FOR THE SECOND QUARTER

        REVENUES FOR THE QUARTER  ended June 30, 2004  increased to $9.9 million
as  compared  with $3.5  million  for the  corresponding  period  of 2003.  This
increase is largely  attributed to strong sales in the Company's Armored Vehicle
Division,  as  well  as  the  addition  of the  results  of  the  Company's  new
acquisitions, FAAC and Epsilor, to its results.

        GROSS  PROFIT for the  quarter  ended June 30,  2004  increased  to $3.4
million (with a gross margin of 34%) as compared with $1.0 million (with a gross
margin of 29%) for the  corresponding  period of 2003.  This increase is largely


                                     (more)


attributed to strong sales in the Company's Armored Vehicle Division, as well as
the addition of the results of the Company's new acquisitions, FAAC and Epsilor,
to its results.

        ADJUSTED LOSS BEFORE  INTEREST,  TAXES,  DEPRECIATION  AND  AMORTIZATION
(ADJUSTED LBITDA),  excluding discontinued  operations and adjusted to eliminate
certain non-cash charges described below and in the table below, for the quarter
ended June 30, 2004  decreased to $857,000 as compared with $1.1 million for the
corresponding  period of 2003.  Arotech  believes  that  information  concerning
Adjusted  LBITDA  enhances  overall   understanding  of  its  current  financial
performance  and its  progress  towards  cash-flow  break even and  toward  GAAP
profitability.  Arotech computes Adjusted LBITDA,  which is a non-GAAP financial
measure, as reflected in the table below.

        NET LOSS for the quarter  ended June 30, 2004  increased to $4.4 million
as compared with $2.5 million for the corresponding  quarter of 2003,  primarily
as a result of non-cash charges.

        BASIC AND DILUTED NET LOSS PER SHARE for the quarter ended June 30, 2004
was $0.07 as compared with $0.07 for the corresponding period of 2003.

RESULTS FOR THE FIRST HALF

        REVENUES  FOR THE SIX MONTHS  ended  June 30,  2004  increased  to $17.1
million as compared with $7.5 million for the corresponding period of 2003. This
increase is largely  attributed to strong sales in the Company's Armored Vehicle
Division,  as  well  as  the  addition  of the  results  of  the  Company's  new
acquisitions, FAAC and Epsilor, to its results.

        GROSS  PROFIT for the six months  ended June 30, 2004  increased to $6.0
million (with a gross margin of 35%) as compared with $2.4 million (with a gross
margin of 32%) for the  corresponding  period of 2003.  This increase is largely
attributed to strong sales in the Company's Armored Vehicle Division, as well as
the addition of the results of the Company's new acquisitions, FAAC and Epsilor,
to its results.

        ADJUSTED LOSS BEFORE  INTEREST,  TAXES,  DEPRECIATION  AND  AMORTIZATION
(ADJUSTED LBITDA),  excluding discontinued  operations and adjusted to eliminate
certain  non-cash  charges  described below and in the table below,  for the six
months  ended June 30, 2004  decreased  to $1.5  million as  compared  with $1.7
million for the corresponding  period of 2003. Arotech believes that information
concerning  Adjusted  LBITDA  enhances  overall  understanding  of  its  current
financial  performance and its progress towards  cash-flow break even and toward
GAAP  profitability.  Arotech  computes  Adjusted  LBITDA,  which is a  non-GAAP
financial measure, as reflected in the table below.

        NET LOSS  for the six  months  ended  June 30,  2004  increased  to $8.7
million as  compared  with $3.8  million for the  corresponding  period of 2003,
primarily as a result of non-cash charges.

        BASIC AND DILUTED  NET LOSS PER SHARE for the six months  ended June 30,
2004 increased to $0.14 as compared with $0.11 for the  corresponding  period of
2003.

CASH POSITION AT QUARTER END

        CASH-ON-HAND AND CASH EQUIVALENTS,  RESTRICTED  COLLATERAL  DEPOSITS AND
OTHER RESTRICTED CASH, AND AVAILABLE-FOR-SALE MARKETABLE SECURITIES stood at the
end of the  quarter  at  $5.1  million  in  cash,  $8.9  million  in  restricted


                                     (more)


collateral  securities  and cash  deposits due within one year,  $2.0 million in
long-term  restricted  securities  and  deposits,  and  $127,000  in  marketable
securities,  as  compared  to at the end of 2003,  when the  Company  had  $13.7
million in cash and $706,000 in restricted cash deposits due within one year.

        STOCKHOLDERS'  EQUITY  stood at the end of the quarter at  approximately
$44.7 million.

ABOUT AROTECH CORPORATION

        Arotech  Corporation  provides quality defense and security products for
the military, law enforcement and homeland security markets,  including advanced
zinc-air   and  lithium   batteries   and   chargers,   multimedia   interactive
simulators/trainers and lightweight armoring.

        The Battery and Power Systems  Division  includes  Electric Fuel Battery
Corporation and Epsilor Electronic Industries Ltd. The Simulation,  Training and
Consulting  Division  includes IES Interactive  Training,  FAAC Incorporated and
Arocon Security Consulting.  The Armoring Division includes MDT Armor Corp., MDT
Protective Industries Ltd. and Armour of America, Incorporated.

        Arotech is incorporated in Delaware, with corporate offices in New York,
and research,  development  and production  subsidiaries  in Alabama,  Colorado,
Michigan, California and Israel.

COMPANY CONTACT:
Jonathan Whartman
Senior VP, Communications
1-866-325-6963
whartman@arotech.com
NY Office 1-212-258-3222

EXCEPT FOR THE HISTORICAL INFORMATION HEREIN, THE MATTERS DISCUSSED IN THIS NEWS
RELEASE INCLUDE FORWARD-LOOKING STATEMENTS, AS DEFINED IN THE PRIVATE SECURITIES
LITIGATION REFORM ACT OF 1995. READERS ARE CAUTIONED NOT TO PLACE UNDUE RELIANCE
ON THESE  FORWARD-LOOKING  STATEMENTS,  AS THEY ARE SUBJECT TO VARIOUS RISKS AND
UNCERTAINTIES THAT MAY CAUSE ACTUAL RESULTS TO VARY  SIGNIFICANTLY.  THESE RISKS
AND  UNCERTAINTIES  INCLUDE,  BUT ARE NOT LIMITED TO, RISKS RELATING TO: PRODUCT
AND  TECHNOLOGY  DEVELOPMENT;  THE  UNCERTAINTY  OF  THE  MARKET  FOR  AROTECH'S
PRODUCTS;  CHANGING ECONOMIC CONDITIONS;  DELAY, CANCELLATION OR NON-RENEWAL, IN
WHOLE OR IN PART,  OF  CONTRACTS OR OF PURCHASE  ORDERS;  AND OTHER RISK FACTORS
DETAILED IN AROTECH'S MOST RECENT ANNUAL REPORT ON FORM 10-K FOR THE FISCAL YEAR
ENDED  DECEMBER  31, 2003 AND OTHER  FILINGS  WITH THE  SECURITIES  AND EXCHANGE
COMMISSION.  AROTECH  ASSUMES NO  OBLIGATION TO UPDATE THE  INFORMATION  IN THIS
RELEASE.   REFERENCE  TO  THE  COMPANY'S   WEBSITE  ABOVE  DOES  NOT  CONSTITUTE
INCORPORATION OF ANY OF THE INFORMATION THEREON INTO THIS PRESS RELEASE.


                                TABLES TO FOLLOW


                                     (more)


                               AROTECH CORPORATION
                CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)



                                                                   SIX MONTHS ENDED JUNE 30,      THREE MONTHS ENDED JUNE 30,
                                                                 ----------------------------    ----------------------------
                                                                      2004           2003            2004            2003
                                                                 ------------    ------------    ------------    ------------
                                                                                                     
Revenues .....................................................   $ 17,110,502    $  7,526,588    $  9,928,248    $  3,493,135
Cost of revenues .............................................     11,131,967       5,112,889       6,574,747       2,479,170
                                                                 ------------    ------------    ------------    ------------
Gross profit .................................................      5,978,535       2,413,699       3,353,501       1,013,965
                                                                 ------------    ------------    ------------    ------------
Research and development expenses ............................        871,627         510,544         408,121         152,505
Sales and marketing expenses .................................      2,140,696       1,637,576       1,119,611         933,589
General and administrative expenses ..........................      7,202,454       2,473,507       3,521,461       1,460,752
Amortization of intangible assets ............................        992,025         623,543         496,013         311,771
                                                                 ------------    ------------    ------------    ------------
                                                                   11,206,802       5,245,170       5,545,206       2,858,617
                                                                 ------------    ------------    ------------    ------------
Operating loss ...............................................     (5,228,267)     (2,831,471)     (2,191,705)     (1,844,652)
Financial (expenses) income, net .............................     (3,259,530)       (983,821)     (1,985,576)       (725,609)
                                                                 ------------    ------------    ------------    ------------
Net loss before taxes ........................................     (8,487,797)     (3,815,292)     (4,177,281)     (2,570,261)
Tax expenses .................................................       (170,065)       (277,047)       (174,972)       (274,185)
                                                                 ------------    ------------    ------------    ------------
Net loss before minority interest in profit of subsidiary ....     (8,657,862)     (4,092,339)     (4,352,253)     (2,844,446)
Loss (profit) to minority ....................................        (26,708)        160,298         (26,162)        203,526
                                                                 ------------    ------------    ------------    ------------
Net loss from continuing operations ..........................   $ (8,684,570)   $ (3,932,041)   $ (4,378,415)   $ (2,640,920)
Profit from discontinued operations ..........................             --          83,166              --         179,127
                                                                 ------------    ------------    ------------    ------------
Net loss for the period ......................................   $ (8,684,570)   $ (3,848,875)   $ (4,378,415)   $ (2,461,793)
                                                                 ============    ============    ============    ============

=============================================================================================================================
Basic and diluted net loss per share for continuing operations   $      (0.14)   $      (0.11)   $      (0.07)   $      (0.07)
                                                                 ============    ============    ============    ============
Basic and diluted net profit per share for discontinued ......   $         --    $       0.00    $         --    $       0.00
operations
                                                                 ============    ============    ============    ============
Combined basic and diluted net loss per share ................   $      (0.14)   $      (0.11)   $      (0.07)   $      (0.07)
                                                                 ============    ============    ============    ============
Weighted average number of shares outstanding ................     62,035,532      35,678,067      64,499,090      36,209,872
                                                                 ============    ============    ============    ============
=============================================================================================================================


RECONCILIATION OF NON-GAAP FINANCIAL MEASURE

         To supplement Arotech's  consolidated financial statements presented in
accordance with GAAP,  Arotech uses a non-GAAP  measure,  Loss Before  Interest,
Taxes,  Depreciation and Amortization (LBITDA), as adjusted to eliminate certain
non-cash charges (Adjusted LBITDA). This non-GAAP measure is provided to enhance
overall  understanding  of  Arotech's  current  financial  performance  and  its
progress   towards   cash-flow   break  even  and  toward  GAAP   profitability.
Reconciliation of Adjusted LBITDA to the nearest GAAP measure follows:



                                                           ADJUSTED LBITDA
-----------------------------------------------------------------------------------------------------------------------------
                                                                   SIX MONTHS ENDED JUNE 30,      THREE MONTHS ENDED JUNE 30,
                                                                 ----------------------------    ----------------------------
                                                                      2004           2003            2004            2003
                                                                 ------------    ------------    ------------    ------------
                                                                                                     
Net loss from continuing operations (GAAP measure) ...........   $ (8,684,570)   $ (3,932,041)   $ (4,378,415)   $ (2,640,920)
Add back:
Interest expense (income), net (after deduction of minority
  interest) ..................................................      3,261,118         976,544       1,984,996         733,940
Taxes (after deduction of minority interest) .................        154,290         142,696         159,196         142,696
Depreciation of fixed assets .................................        518,332         348,401         281,924         167,810
Amortization of intangible assets ............................      1,010,351         623,543         505,175         311,772
                                                                 ------------    ------------    ------------    ------------
LBITDA (non-GAAP measure) ....................................   $ (3,740,479)   $ (1,840,858)   $ (1,447,124)   $ (1,284,703)
                                                                 ============    ============    ============    ============
Add back certain non-cash charges:
  Expenses  attributed  on issuance of shares and options to
    consultants and employees ................................        460,861         184,090         441,081         184,090
  Expenses  attributed on repricing and issuance of warrants
    to investors .............................................      1,742,384               0         149,527               0
                                                                 ------------    ------------    ------------    ------------
ADJUSTED LBITDA (non-GAAP measure) ...........................   $ (1,537,234)   $ (1,656,768)   $   (856,516)   $ (1,100,613)
                                                                 ============    ============    ============    ============



                                    # # # # #


                                     (end)